Cyclophosphamide from Shilpa Medicare Ltd

Started its operations as API manufacturer way back in 1987 at Raichur, Karnataka- India. The commercial production in the SML was started in November 1989. Today Shilpa Medicare Limited is a global brand in manufacturing and supplying of affordable API and Formulation globally in different regulated markets.

Shilpa Medicare is a fully integrated pharmaceutical company, present across the entire value chain from Research and Development, Active Pharmaceutical Ingredients, Finished Formulations, Biologicals, ODF, Derma, Peptides & Polymers etc.

Currently we are one of the leaders in the Oncology market and offer a complete range of products in this segment spanning across APIs, formulations both in terms of R&D and manufacturing capabilities. Further to consolidation in field of oncology API and formulations, we are striving to put in our efforts in field of novel...

Read full company description
Address: #12-6-214/A1, Hyderabad Road, Raichur, 584 135, Karnataka
India
India Local time:

6 production facilities approved by USFDA, AGES-Austria, PMDA, WHO

R&D Centers with capabilities of ANDAs, DMFs and NDDS

462+ patents filed for drug substances and polymorphs

Our clients:

All API Buyers

Our services:

API
Albumin
Biologics
Formulation
CDMO
Polymer

Response time:

Produced in:

India

MOQ: -

  • GMP

  • CoA

  • ISO9001

  • WC

  • MSDS

  • BSE/TSE

  • USDMF

Contact supplier

Replies quickly

Shilpa Medicare Ltd Cyclophosphamide API Producer - 50-18-0

Description:
Shilpa Medicare Ltd offers high-quality Cyclophosphamide API, certified for compliance with international standards. Manufactured in India. 6 production facilities approved by USFDA, AGES-Austria, PMDA, WHO. R&D Centers with capabilities of ANDAs, DMFs and NDDS. 462+ patents filed for drug substances and polymorphs.

Product Details

Certifications
GMP, CoA, ISO9001, WC, MSDS, BSE/TSE, USDMF compliant
Minimum Order Quantity
Produced in
India (Asia)
DrugBank ID
DB00531
CAS Number
50-18-0
Unique Ingredient Identifier
6UXW23996M
Raw Material Category
Alkylating agents

Ordering Process

1. Inquiry Submission: Click "Send Inquiry" to connect directly with producer.

2. Requirement Specification: Outline your needs for tailored offers.

3. Quotation: Receive the best quote and terms exclusively through Pharmaoffer.

Additional Products

We offer 53 other Active Pharmaceutical Ingredients and excipients, showcasing our production and distribution capabilities.

Contact Us

Are you looking for Cyclophosphamide API? Contact Shilpa Medicare Ltd by using the send inquiry button. We will respond quickly with pricing and terms exclusively through Pharmaoffer.

Please, provide enough information regarding your inquiry. Let us know whether you require Ph.Eur (EP), USP, BP, JP grade, whether you are looking for hydrochloride (HCl), base, or other specific product specifications. Additionally, please inform us if the API is intended for your own production, resale, or research purposes. Contact us to receive a quote, download certificates, and purchase the Cyclophosphamide API

Shilpa Medicare Ltd


Started its operations as API manufacturer way back in 1987 at Raichur, Karnataka- India. The commercial production in the SML was started in November 1989. Today Shilpa Medicare Limited is a global brand in manufacturing and supplying of affordable API and Formulation globally in different regulated markets.

Shilpa Medicare is a fully integrated pharmaceutical company, present across the entire value chain from Research and Development, Active Pharmaceutical Ingredients, Finished Formulations, Biologicals, ODF, Derma, Peptides & Polymers etc.

Currently we are one of the leaders in the Oncology market and offer a complete range of products in this segment spanning across APIs, formulations both in terms of R&D and manufacturing capabilities. Further to consolidation in field of oncology API and formulations, we are striving to put in our efforts in field of novel drug delivery systems and biotech products along with widening our focus to other therapy are